Compare $PVLA vs $VCEL | Chartloom

Compare

$PVLA vs $VCEL

Palvella Therapeutics Inc · Vericel Corp

PVLA

Palvella Therapeutics Inc

VCEL

Vericel Corp

Compare $PVLA vs $VCEL

Comparing Palvella Therapeutics Inc and Vericel Corp

PVLAPalvella Therapeutics Inc

VCELVericel Corp

PVLAPalvella Therapeutics Inc

Market cap

$1.99B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-97.2%

YTD performance

38.4%

52W performance

85.4%

FCF yield

-1.8%

VCELVericel Corp

Market cap

$2.05B

P/E (TTM)

86.61x

Forward P/E (NTM)

55.49x

Forward P/S (NTM)

5.56x

Rev growth (TTM)

23.0%

YTD performance

12.6%

52W performance

17.5%

FCF yield

3.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

PVLA

VCEL

Detailed metrics comparison

PVLA

Palvella Therapeutics Inc

VCEL

Vericel Corp

Market Cap

PVLA$1.99B

VCEL$2.05B

Enterprise Value

PVLA$1.82B

VCEL$1.92B

Price

PVLA$138.77

VCEL$40.10

P/E Ratio

PVLAN/A

VCEL86.61x

P/S Ratio

PVLA46.64x

VCEL6.69x

EV/Sales

PVLA0.00x

VCEL6.28x

EV/EBITDA

PVLA0.00x

VCEL58.45x

P/B Ratio

PVLA8.80x

VCEL5.56x

P/FCF Ratio

PVLAN/A

VCEL33.21x

EV/FCF

PVLA-49.96x

VCEL31.19x

PEG Ratio

PVLAN/A

VCEL0.32x

Forward P/E (NTM)

PVLAN/A

VCEL55.49x

Forward P/S (NTM)

PVLAN/A

VCEL5.56x

Revenue (TTM)

PVLA$0

VCEL$306M

Revenue Growth (YoY)

PVLA-97.2%

VCEL23.0%

Forward Rev Growth

PVLA287.4%

VCEL16.9%

Gross Margin (TTM)

PVLA0.0%

VCEL74.6%

Operating Margin (TTM)

PVLA0.0%

VCEL6.0%

EBITDA Margin (TTM)

PVLA0.0%

VCEL10.2%

Net Margin (TTM)

PVLA0.0%

VCEL7.9%

FCF Margin (TTM)

PVLAN/A

VCEL20.1%

Net Income (TTM)

PVLA$-62M

VCEL$24M

FCF (TTM)

PVLA$-37M

VCEL$62M

EPS (TTM)

PVLA-$4.30

VCEL$0.46

ROE (TTM)

PVLA-4784.0%

VCEL6.9%

ROA (TTM)

PVLA-3833.0%

VCEL5.0%

ROIC (TTM)

PVLA-4172.0%

VCEL6.9%

Cash

PVLA$188M

VCEL$125M

Debt

PVLA$22M

VCEL$596K

Net Cash/Debt

PVLA$166M

VCEL$125M

Current Ratio (TTM)

PVLA21.18x

VCEL5.04x

Quick Ratio (TTM)

PVLA21.01x

VCEL4.69x

Debt/Equity (TTM)

PVLA0.10x

VCEL0.00x

Debt/Assets (TTM)

PVLA0.0%

VCEL0.0%

Interest Coverage (TTM)

PVLAN/A

VCELN/A

Net Debt/EBITDA (TTM)

PVLA0.00x

VCEL0.00x

Beta

PVLA-0.19

VCEL1.06

52W Performance

PVLA85.4%

VCEL17.5%

YTD Performance

PVLA38.4%

VCEL12.6%

% from 52W High

PVLA-14.0%

VCEL-18.7%

% from 52W Low

PVLA110.5%

VCEL38.5%

Asset Turnover (TTM)

PVLA0.76x

VCEL0.63x

FCF Yield (TTM)

PVLA-1.8%

VCEL3.0%

Earnings Yield (TTM)

PVLA-3.1%

VCEL1.2%

Dividend Yield (TTM)

PVLAN/A

VCELN/A

Rule of 40

PVLA-97.2

VCEL43.1

EV/GP/RG

PVLAN/A

VCEL0.39

Ticker research

View PVLA research View VCEL research

Metric	PVLA Palvella Therapeutics Inc	VCEL Vericel Corp
Market & Valuation
Market Cap	$1.99B	$2.05B
Enterprise Value	$1.82B	$1.92B
Price	$138.77	$40.10
P/E Ratio	N/A	86.61x
P/S Ratio	46.64x	6.69x
EV/Sales	0.00x	6.28x
EV/EBITDA	0.00x	58.45x
P/B Ratio	8.80x	5.56x
P/FCF Ratio	N/A	33.21x
EV/FCF	-49.96x	31.19x
PEG Ratio	N/A	0.32x
Forward P/E (NTM)	N/A	55.49x
Forward P/S (NTM)	N/A	5.56x
Revenue & Growth
Revenue (TTM)	$0	$306M
Revenue Growth (YoY)	-97.2%	23.0%
Forward Rev Growth	287.4%	16.9%
Profitability
Gross Margin (TTM)	0.0%	74.6%
Operating Margin (TTM)	0.0%	6.0%
EBITDA Margin (TTM)	0.0%	10.2%
Net Margin (TTM)	0.0%	7.9%
FCF Margin (TTM)	N/A	20.1%
Net Income (TTM)	$-62M	$24M
FCF (TTM)	$-37M	$62M
EPS (TTM)	-$4.30	$0.46
ROE (TTM)	-4784.0%	6.9%
ROA (TTM)	-3833.0%	5.0%
ROIC (TTM)	-4172.0%	6.9%
Financial Health
Cash	$188M	$125M
Debt	$22M	$596K
Net Cash/Debt	$166M	$125M
Current Ratio (TTM)	21.18x	5.04x
Quick Ratio (TTM)	21.01x	4.69x
Debt/Equity (TTM)	0.10x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.19	1.06
52W Performance	85.4%	17.5%
YTD Performance	38.4%	12.6%
% from 52W High	-14.0%	-18.7%
% from 52W Low	110.5%	38.5%
Efficiency & Yields
Asset Turnover (TTM)	0.76x	0.63x
FCF Yield (TTM)	-1.8%	3.0%
Earnings Yield (TTM)	-3.1%	1.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-97.2	43.1
EV/GP/RG	N/A	0.39
Ticker research	View PVLA research	View VCEL research

Valuation

P/E Ratio

VCEL

86.61x

P/S Ratio

VCEL

6.69x

PVLA

46.64x

EV/FCF

PVLA

-49.96x

VCEL

31.19x

Growth & revenue

Revenue Growth TTM

VCEL

23.0%

PVLA

-97.2%

Forward Revenue Growth

PVLA

287.4%

VCEL

16.9%

Profitability & performance

Gross Margin

VCEL

74.6%

PVLA

0.0%

ROE

VCEL

6.9%

PVLA

-4784.0%

FCF Yield %

VCEL

3.0%

PVLA

-1.8%

52-Week Performance

PVLA

85.4%

VCEL

17.5%

Detailed metrics comparison

PVLA

Palvella Therapeutics Inc

VCEL

Vericel Corp

Market Cap

PVLA$1.99B

VCEL$2.05B

Enterprise Value

PVLA$1.82B

VCEL$1.92B

Price

PVLA$138.77

VCEL$40.10

P/E Ratio

PVLAN/A

VCEL86.61x

P/S Ratio

PVLA46.64x

VCEL6.69x

EV/Sales

PVLA0.00x

VCEL6.28x

EV/EBITDA

PVLA0.00x

VCEL58.45x

P/B Ratio

PVLA8.80x

VCEL5.56x

P/FCF Ratio

PVLAN/A

VCEL33.21x

EV/FCF

PVLA-49.96x

VCEL31.19x

PEG Ratio

PVLAN/A

VCEL0.32x

Forward P/E (NTM)

PVLAN/A

VCEL55.49x

Forward P/S (NTM)

PVLAN/A

VCEL5.56x

Revenue (TTM)

PVLA$0

VCEL$306M

Revenue Growth (YoY)

PVLA-97.2%

VCEL23.0%

Forward Rev Growth

PVLA287.4%

VCEL16.9%

Gross Margin (TTM)

PVLA0.0%

VCEL74.6%

Operating Margin (TTM)

PVLA0.0%

VCEL6.0%

EBITDA Margin (TTM)

PVLA0.0%

VCEL10.2%

Net Margin (TTM)

PVLA0.0%

VCEL7.9%

FCF Margin (TTM)

PVLAN/A

VCEL20.1%

Net Income (TTM)

PVLA$-62M

VCEL$24M

FCF (TTM)

PVLA$-37M

VCEL$62M

EPS (TTM)

PVLA-$4.30

VCEL$0.46

ROE (TTM)

PVLA-4784.0%

VCEL6.9%

ROA (TTM)

PVLA-3833.0%

VCEL5.0%

ROIC (TTM)

PVLA-4172.0%

VCEL6.9%

Cash

PVLA$188M

VCEL$125M

Debt

PVLA$22M

VCEL$596K

Net Cash/Debt

PVLA$166M

VCEL$125M

Current Ratio (TTM)

PVLA21.18x

VCEL5.04x

Quick Ratio (TTM)

PVLA21.01x

VCEL4.69x

Debt/Equity (TTM)

PVLA0.10x

VCEL0.00x

Debt/Assets (TTM)

PVLA0.0%

VCEL0.0%

Interest Coverage (TTM)

PVLAN/A

VCELN/A

Net Debt/EBITDA (TTM)

PVLA0.00x

VCEL0.00x

Beta

PVLA-0.19

VCEL1.06

52W Performance

PVLA85.4%

VCEL17.5%

YTD Performance

PVLA38.4%

VCEL12.6%

% from 52W High

PVLA-14.0%

VCEL-18.7%

% from 52W Low

PVLA110.5%

VCEL38.5%

Asset Turnover (TTM)

PVLA0.76x

VCEL0.63x

FCF Yield (TTM)

PVLA-1.8%

VCEL3.0%

Earnings Yield (TTM)

PVLA-3.1%

VCEL1.2%

Dividend Yield (TTM)

PVLAN/A

VCELN/A

Rule of 40

PVLA-97.2

VCEL43.1

EV/GP/RG

PVLAN/A

VCEL0.39

Ticker research

View PVLA research View VCEL research

Metric	PVLA Palvella Therapeutics Inc	VCEL Vericel Corp
Market & Valuation
Market Cap	$1.99B	$2.05B
Enterprise Value	$1.82B	$1.92B
Price	$138.77	$40.10
P/E Ratio	N/A	86.61x
P/S Ratio	46.64x	6.69x
EV/Sales	0.00x	6.28x
EV/EBITDA	0.00x	58.45x
P/B Ratio	8.80x	5.56x
P/FCF Ratio	N/A	33.21x
EV/FCF	-49.96x	31.19x
PEG Ratio	N/A	0.32x
Forward P/E (NTM)	N/A	55.49x
Forward P/S (NTM)	N/A	5.56x
Revenue & Growth
Revenue (TTM)	$0	$306M
Revenue Growth (YoY)	-97.2%	23.0%
Forward Rev Growth	287.4%	16.9%
Profitability
Gross Margin (TTM)	0.0%	74.6%
Operating Margin (TTM)	0.0%	6.0%
EBITDA Margin (TTM)	0.0%	10.2%
Net Margin (TTM)	0.0%	7.9%
FCF Margin (TTM)	N/A	20.1%
Net Income (TTM)	$-62M	$24M
FCF (TTM)	$-37M	$62M
EPS (TTM)	-$4.30	$0.46
ROE (TTM)	-4784.0%	6.9%
ROA (TTM)	-3833.0%	5.0%
ROIC (TTM)	-4172.0%	6.9%
Financial Health
Cash	$188M	$125M
Debt	$22M	$596K
Net Cash/Debt	$166M	$125M
Current Ratio (TTM)	21.18x	5.04x
Quick Ratio (TTM)	21.01x	4.69x
Debt/Equity (TTM)	0.10x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.19	1.06
52W Performance	85.4%	17.5%
YTD Performance	38.4%	12.6%
% from 52W High	-14.0%	-18.7%
% from 52W Low	110.5%	38.5%
Efficiency & Yields
Asset Turnover (TTM)	0.76x	0.63x
FCF Yield (TTM)	-1.8%	3.0%
Earnings Yield (TTM)	-3.1%	1.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-97.2	43.1
EV/GP/RG	N/A	0.39
Ticker research	View PVLA research	View VCEL research